Product NDC: | 60505-3547 |
Proprietary Name: | IRBESARTAN |
Non Proprietary Name: | IRBESARTAN |
Active Ingredient(s): | 75 mg/1 & nbsp; IRBESARTAN |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60505-3547 |
Labeler Name: | Apotex Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA200832 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121016 |
Package NDC: | 60505-3547-3 |
Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (60505-3547-3) |
NDC Code | 60505-3547-3 |
Proprietary Name | IRBESARTAN |
Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (60505-3547-3) |
Product NDC | 60505-3547 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | IRBESARTAN |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20121016 |
Marketing Category Name | ANDA |
Labeler Name | Apotex Corp. |
Substance Name | IRBESARTAN |
Strength Number | 75 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |